Background Idiopathic inflammatory myopathy (IIM) is a multi-system autoimmune condition
characterised by muscle inflammation (myositis), interstitial lung disease (ILD), and skin …

Interstitial lung disease (ILD) is a very important complication of the idiopathic inflammatory
myositides (IIM), with a prevalence of approximately 40 %. Characteristic HRCT changes, …

… Patrick DW Kiely Patrick DW Kiely … Patrick DW Kiely, Biologic efficacy optimization—a step
towards personalized medicine, Rheumatology, Volume 55, Issue 5, May 2016, Pages 780–…

… MANSELL,1 PATRICK DW KIELY,2 ADAM YOUNG,3 AND DAVID A. WALSH4 … Kiely P,
Williams R, Walsh D, Young A. Contemporary patterns of care and disease activity outcome in …

Objective To develop EULAR points-to-consider for therapeutic drug monitoring (TDM) of
biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases (RMDs). …

Objective. RA has a substantial impact on both patients and healthcare systems. Our
objective is to advance the understanding of modern management principles in light of recent …

Background DAS28 is interpreted as the inflammatory disease activity of RA. Non-inflammatory
pain mechanisms can confound assessment. We aimed to examine the use of DAS28 …

Objective To investigate how social support, financial status, and lifestyle influence the
development of excess disability in rheumatoid arthritis (RA). Methods Data were obtained from …

… Patrick DW Kiely , Patrick DW Kiely … Elena Nikiphorou, Sam J Norton, Lewis Carpenter,
David A Walsh, Paul Creamer, Josh Dixey, Adam Young, Patrick DW Kiely, for ERAS and ERAN, …

Objective. Optimizing therapeutic strategies to induce remission requires an understanding
of the initial features predicting remission. Currently no suitable model exists. We aim to …